18 F-fluorodeoxyglucose (FDG) PET-CT using several quantification criteria. Uniform criteria for data analysis became available recently (BARCIST 1.0). We compared BAT volume and activity following BARCIST 1.0 criteria against the most commonly used criteria [Hounsfield Units (HU):-250, -50, standardized uptake value (SUV):2.0; HU: Not applied, SUV:2.0 and HU:-180, -10, SUV:1.5] in a prospective study using three independent cohorts of men including young lean adults, young overweight/obese adults and middle-aged overweight/obese adults. BAT volume was the most variable outcome between criteria. While BAT volume calculated using the HU: NA; SUV: 2.0 criteria was up to 207% higher than the BAT volume calculated based on BARCIST 1.0 criteria, it was up to 57% lower using the HU: -250, -50; SUV: 2.0 criteria compared to the BARCIST 1.0. Similarly, BAT activity (expressed as SUV mean ) also differed between different thresholds mainly because SUV mean depends on BAT volume. SUV peak was the most consistent BAT outcome across the four study criteria. Of note, we replicated these findings in three independent cohorts. In conclusion, BAT volume and activity as determined by 18 F-FDG-PET/CT highly depend on the quantification criteria used. Future human BAT studies should conduct sensitivity analysis with different thresholds in order to understand whether results are driven by the selected HU and/or SUV thresholds. The design of the present study precludes providing any conclusive threshold, but before more definitive thresholds for HU and SUV are available, we support the use of BARCIST 1.0 criteria to facilitate interpretation of BAT characteristics between research groups.
allows the identification of various tissues, including adipose tissue and soft tissues, based on the radio-density expressed as Hounsfield units (HU). Therefore, quantification of BAT volume and activity depends to a great extent on the selection and combination of HU and SUV thresholds 1 . Due to the lack of consensus on the most appropriate HU and SUV thresholds to quantify BAT volume and activity in humans, studies have shown different levels of BAT volume and activity in cohorts with similar characteristics 10, 11 . Consequently, since optimal thresholds are not known, current available data on human BAT volume and activity are speculative at best. Moreover, the use of different HU and SUV thresholds hampers comparability across studies.
Recently, an expert panel launched a set of recommendations for conducting 18 F-FDG-PET/CT analysis of human BAT (Brown Adipose Reporting Criteria in Imaging Studies, BARCIST 1.0) 1 . BARCIST 1.0 recommends using a HU range between -190 and -10, and a SUV threshold of [1.2/(lean body mass (LBM)/body mass (BM))]. The impact of using the BARCIST 1.0 HU and SUV thresholds compared to the most commonly used protocols to quantify BAT volume and activity is currently unknown since, to our knowledge, no studies using these specific thresholds have been reported yet. It is of interest to better understand the relative differences obtained with BARCIST 1.0 thresholds compared to the currently most commonly used thresholds in literature for populations with different age and BMI.
Therefore, in the present study we aimed to compare and quantify BAT volume and activity following BARCIST 1.0 recommendations against the most commonly used HU and SUV thresholds in three different cohorts of men including young lean adults, young overweight/obese adults, and middle-aged overweight/obese adults.
Methods

Participants.
A total of thirty men from three independent cohorts were included in this prospectively designed study. Participants' characteristics are shown in Table 1 . The study cohorts were: (i) 10 young lean adults (21- 13 , and (iii) 10 middle-aged overweight/obese adults (35-53 years old; BMI 26-30 kg/m 2 ). The study conducted in young overweight/obese adults was approved by the Human Research Ethics Committee of both University of Granada (n°924) and Servicio Andaluz de Salud (Centro de Granada, CEI-Granada). The Medical Ethical Committee of the Leiden University Medical Center approved the other study cohorts (2473 and NCT02294084). All volunteers provided written informed consent before participation. All studies were performed in accordance with the Declaration of Helsinki.
Systematic review on most commonly used thresholds. To used the Medical Subject Heading (MeSH) terms "Adipose Tissue, Brown" in combination with type of population (men, women, and adults) and instrument used ("PET/CT", "PET-CT", and "18-FDG"). We excluded human studies that did not use 18 F-FDG-PET/CT scans to assess BAT volume and activity, studies conducted in animal models or not written in English, and reviews. In addition, we searched the reference lists of all identified relevant publications. No restrictions were considered regarding study design (cross sectional, case-control, cohort study) or data collection (prospective or retrospective). To avoid duplicate data, we identified articles that included the same group of participants by reviewing inter-study similarities in any of the following characteristics: country in which the study was conducted, investigators who performed the study, source of patients, recruitment period, and inclusion criteria. When the same investigators reported results obtained on the same group of patients in several publications, only the first published study was included.
Cooling protocol. To activate BAT, we applied personalized cooling protocols prior to 18 F-FDG-PET/CT scans. Slightly different water-cooling methods were used between the different cohorts due to differences in local equipment and protocols. In the young lean and middle-aged overweight/obese cohorts two water-perfused temperature-controlled mattresses (Blanketrol III, Cincinnati Sub-Zero Products, Cincinnati, OH, USA) were used, as previously described 12 . In short, participants were sandwiched between two water-perfused mattresses starting at a temperature of 32 °C, which was subsequently gradually decreased. When shivering occurred (after 30-40 min), temperature was raised by 3-4 °C and a stable cooling period of 2 h started. In the cohort of young overweight/obese adults a water perfused vest (Polar Products Inc., Ohio, USA) was used 14 . Shivering threshold was determined 48-72 h before the 18 F-FDG-PET/CT scan. Immediately before the 18 F-FDG-PET/CT scan, participants wore the water perfused vest for 2 h set at approx. 4 °C above the temperature that caused the onset of shivering. In all three studies, after 1 h of stable cooling 18 F-FDG was injected (Table 1) and after 2 h of cooling 18 F-FDG-PET/CT imaging was performed.
Body composition. Fat mass and lean body mass were measured by Dual Energy X-ray Absorptiometry (DEXA) in the three cohorts (Table 1) .
F-FDG-PET/CT scan.
Cold-induced BAT volume and activity were assessed by 18 F-FDG-PET/CT scanning. Table 1 shows details of the PET/CT scanners as well as doses of 18 F-FDG injected in each study cohort. In the three studies, for the CT acquisition a peak kilovoltage of 120 was applied, while for the PET acquisition a scan time of 6 min per bed position was set. In total, 6 bed positions were scanned for the young lean and middle-aged overweight/obese adults (from top of the head to pelvis) and 2 bed positions for the young overweight/obese adults (from atlas vertebra to mid-chest, which was a requirement set by the Human Research Ethics Committee to limit radiation burden).
Quantification of human BAT volume and activity. PET/CT images were analyzed using the Beth Israel plugin for FIJI 2 software by two trained researchers (BMT and KJN) 15 . Disagreements between both researchers were arranged in a consensus meeting. The regions of interest (ROIs) were semi-automatically outlined from atlas vertebrae (Cervical 1) to thoracic vertebrae 4 (see Figure S1 ) using a 3D-Axial technique 11 . The ROIs were placed in this range because (i) this region predominantly shows BAT activity and (ii) it is the region that is consistently scanned in all three study cohorts. Regions such as mouth, nose, or thyroid were not included to avoid potential false positives within the ROIs. We calculated the standardized uptake value (SUV) as
. We defined BAT volume, SUV mean , BAT metabolic activity, SUV max and SUV peak following BARCIST 1.0 criteria 1 . In short, BAT volume was calculated as the sum of the volumes identified as BAT in each ROI (1 to 6, see Figure S1 ). SUV mean was calculated by the weighted average of SUV mean derived from each ROI (1 to 6). SUV peak was the highest average SUV in a 1 ml spherical volume. This sphere may, or may not, be centered on the highest SUV max over all ROIs (1 to 6). We also drew a ROI on the descending aorta as reference tissue (Table 1) 1 . To quantify BAT, we applied the criteria of BARCIST 1.0, in addition to the three most used combinations of thresholds detected in the systematic review (see below).
Statistical analysis. Differences across HU and SUV thresholds were analyzed using analysis of variance (ANOVA) with Bonferroni adjustments for post-hoc comparisons. Separate analyses were conducted for each study cohort. The inter-observer (BMT and KJN) reliability was assessed using Lin's concordance coefficient (LCC) 16 . All analyses were conducted using the Statistical Package for Social Sciences (SPSS, v. 22.0, IBM SPSS Statistics, IBM Corporation) and the level of significance was set to ≤0.05. Data are presented as mean ± standard deviation unless otherwise stated.
Results
Characteristics of participants. Table 1 summarizes the characteristics of the participants and the study conditions in the three cohorts.
Systematic review: Selection of HU and SUV thresholds. After having read titles and abstracts, 344 studies were excluded from a total of 471; 131 were checked for relevance (full text); and 123 met the inclusion criteria. After excluding redundant studies, i.e. studies that used the same participants and images, a total of 116 studies were finally included (Table S1 ). Table 2 shows a summary of the HU and SUV thresholds used in the quantification of human BAT by 18 F-FDG-PET/CT. We found nine different combinations of HU and SUV thresholds published twice or more, and 26 different combinations of HU and SUV thresholds published just once. HU and/or SUV thresholds were not mentioned in as many as 32 studies. We selected the three most High inter-observer reliability was found regardless of thresholds applied. Lin's concordance coefficient (LCC) of BAT volume and in the three cohorts was above 0.950, except in one case (0.906; SUV peak in overweight/obese adults; HU: NA, SUV: 2.0; Table S2 ). When BARCIST 1.0 criteria were applied, the LCC were 0.962-0.996, 0.980-0.996 and 0.983-1.000, for BAT volume, SUV mean, and SUV peak , respectively (Table S2 ).
The combination of HU and SUV thresholds markedly affects estimation of BAT volume and activity across different cohorts. Representative images of BAT volume and activity of the three study cohorts resulting from different HU and SUV threshold combinations are shown in Fig. 1 . Firstly, we determined the quantitative effect of the four threshold combinations on BAT volume in young lean adults ( Fig. 2A) , young overweight/obese adults (Fig. 2B) , and middle-aged overweight/obese adults (Fig. 2C) . Compared to the BARCIST 1.0 criteria, higher BAT volumes were consistently observed using the HU: NA; SUV: 2. Table S3 ). No significant differences were observed between BAT volumes estimated by HU: -180, -10; SUV: 1.5 criteria compared to BARCIST 1.0 criteria in young lean adults [0%; 0 (-5, 5) ml], however, we found higher BAT volumes in young overweight/obese adults [+40%; 47 (24, 69) ml] and middle-aged overweight/obese adults [+45%; 38 (18, 58)]. Table S1 for references and details of Hounsfield units, standardized uptake value, and software used to quantify human brown adipose tissue. HU and SUV thresholds moderately affect estimation of BAT activity (SUV mean ) across different cohorts. We next determined the effect of the four threshold combinations on SUV mean in young lean adults (Fig. 2D) , young overweight/obese adults (Fig. 2E) , and middle-aged overweight/obese adults (Fig. 2F) . Compared to the BARCIST 1.0 criteria, higher SUV mean were observed using the HU: -250, -50; SUV: 2.0 criteria in young lean adults [+18%; 0.8 (0.9-0.6) g/ml] and in middle-aged overweight/obese adults [+13%; 0.3 (0.2-0.5) g/ml]. In young lean adults, a lower SUV mean was estimated using the HU: NA; SUV: 2.0 criteria compared to BARCIST 1.0 criteria [-9%; 0.4 (0.2, 0.6) g/ml]. Lower BAT activity was detected using HU: -180, -10; SUV: 1.5 criteria against BARCIST 1.0 criteria in young overweight/obese adults [-14%; 0.5 (0.4, 0.7) g/ml] and middle-aged overweight/obese adults [-11%; 0.3 (0.2-0.4) g/ml] (Table S3) .
HU and SUV thresholds slightly affect estimation of maximal BAT activity (SUV peak ) values across different cohorts. In addition, we determined the effect of the four threshold combinations on SUV peak in young lean adults (Fig. 2G) , young overweight/obese adults (Fig. 2H) , and middle-aged overweight/ obese adults (Fig. 2I) . We found similar results in the SUV peak values (all P > 0.05), however, there were significant differences in the middle-aged overweight/obese adults, where SUV peak values calculated with HU: NA; SUV: 2.0 criteria were higher than calculated with BARCIST 1.0 criteria [+10%; 0.6 (0.2, 0.9) g/ml]. Figure S2 shows means and 95% CI of BAT volume and activity determined by various thresholds of HU and SUV for the three study cohorts.
Discussion
To our knowledge, the present study is the first empirical investigation to compare and quantify BAT volume and activity following BARCIST 1.0 criteria against the most used HU and SUV thresholds in three independent cohorts of men of different age and BMI. We observed that BAT volume calculated using the HU: NA; SUV: 2.0 Table S4 for exact absolute and relative differences between thresholds. criteria may differ up to 2.6-fold, 3.1-fold, and 2.2-fold from the BAT volume calculated based on BARCIST 1.0 criteria in young normal-weight, young overweight/obese, and middle-aged overweight/obese adults, respectively. Similarly, BAT activity (expressed as SUV mean ), based on BARCIST 1.0 criteria differed up to 18% and 13% when compared with BAT activity based on the HU: -250, -50; SUV: 2.0 criteria, for young lean adults and middle-aged overweight/obese adults, respectively. On the other hand, differences were not significant when maximal BAT activity was expressed as SUV peak for young cohorts, while we found that SUV peak based on the HU: NA; SUV: 2.0 was 10% higher than calculated with BARCIST 1.0 criteria in middle-aged overweight/obese adults. The findings of this study show that human BAT volume and to a lesser extent BAT activity (expressed as SUV mean ) depend largely on the selected HU and SUV thresholds. Moreover, we observed that the various threshold combinations similarly influenced BAT volume and BAT activity (SUV mean ) in the three cohorts independently of age, BMI or different methodologies applied to activate and measure BAT 17 .
HU and SUV thresholds markedly affect BAT volume across different cohorts. The scientific community has been speculating about the volume of BAT that is present in adult men, and showed mean values of approx. 70 ml 3 , 100 ml 2, 18 , 300 ml 19 , and 450 ml 20 . This highlights the knowledge gap regarding the amount of BAT present in adults and that maximizing its volume and metabolic activity could impact human physiology. We found that the highest BAT volumes were consistently observed with those thresholds that did not apply a criterion for HU (i.e. HU: NA, SUV: 2.0). Because the gold standard to quantify BAT is the 18 F-FDG-PET in combination with CT, it is evident that a threshold of HU should be applied, although the most appropriate threshold of HU remains to be elucidated. We observed lower BAT volumes with the most frequently used threshold combination in literature (HU: -250, -50, SUV: 2.0) compared to BARCIST 1.0. These differences could be based on the fact that BARCIST 1.0 uses an HU range starting at -10 while the most commonly protocol used an HU range starting at -50, albeit it is known that the range of adipose tissue in the CT images starts at an HU value of -10 11, 21 . Moreover, it was recently shown 22 that the density of the BAT might change after a cold exposure, especially in the range from -50 to -10. Actually, it is not feasible to distinguish BAT from WAT or other tissues using exclusively CT criteria. Thus, more studies are needed to increase our understanding of BAT density measured by a CT scan 23 .
The main advantage of the BARCIST 1.0 recommendations is the inclusion of an individualized SUV threshold adapted to the individual's lean body mass. Estimated BAT volumes did not differ between BARCIST 1.0 and HU: -180, -10; SUV: 1.5 criteria in the young lean adults, probably because the SUV criteria were virtually identical using both thresholds (1.54 ± 0.09 vs. 1.5 g/ml, respectively). Nevertheless, we found higher estimated BAT volume with HU: -180, -10; SUV: 1.5 compared to BARCIST 1.0, because the SUV threshold applied in BARCIST was higher for young overweight/obese adults and middle-aged overweight/obese adults (1.98 ± 0.17 g/ml and 1.75 ± 0.15 g/ml, Table 1 ). Therefore, the relative changes in BAT volume are largely influenced by the use of a SUV threshold corrected by lean body mass 1, 11 . HU and SUV thresholds moderately affect BAT activity (SUV mean ) across different cohorts. SUV mean is the average SUV within a volume, therefore, if BAT volume differs due to HU or SUV thresholds in the three cohorts, SUV mean is also expected to differ by the thresholds selection. Indeed, SUV mean is not consistent across studies as it is influenced by many methodological factors as described previously 17 such as cooling protocols or instruments, as well as study populations 8, 9 . We showed that when a SUV individualized threshold was used and the SUV values are alike (such as HU: -180, -10; SUV: 1.5 criteria in young lean adults), then the SUV mean values are similar. However, we observed that an application of a higher SUV threshold results in higher SUV mean values, regardless of the HU thresholds applied or the cohort studied because the SUV threshold of 2.0 includes higher 18 F-FDG uptake of BAT deposits. On the other hand, when an HU threshold was omitted (i.e. HU: NA; SUV: 2.0 criteria), the SUV mean values were lower regardless of the cohort studied. In this case, all 18 F-FDG present in the selected ROIs of the PET images is used for quantification of BAT activity even though part of 18 F-FDG would represent uptake by other tissues that were not excluded for the analysis due to lack of HU criteria.
HU and SUV thresholds slightly affect maximal BAT activity (SUV peak ) values across different cohorts. BARCIST 1.0 recommends to report SUV peak instead of SUV max to avoid overestimation in the quantification of BAT activity 1 , because SUV max is the single highest uptake pixel in the ROI and could easily be an outlier whereas SUV peak is the highest average SUV in a 1 cc spherical volume, thereby reducing a potential effect of outliers. This sphere may, or may not, be centered on the highest SUV max . Letiner et al. 11 found that PET image resolution substantially influences observed BAT SUV max but whether this resolution also affects SUV peak in currently unknown. Compared to the BARCIST 1.0 criteria, we found similar SUV peak values across thresholds in young lean men and overweight/obese men. However, differences were observed between the thresholds that did not use HU vs. all the other thresholds in middle-aged overweight-obese adults. This could be based on the lower amount of 18 F-FDG injected with respect to the size/body weight of the participant [ratio between amount of 18 F-FDG to BMI (6.8 ± 0.3, 6.5 ± 0.8, and 3.8 ± 0.3 MBq/(kg/m 2 ) in young lean adults, young overweight/obese adults, and middle-aged overweight/obese adults, respectively]. Therefore, the distribution of the tracer among the various tissues may partially explain this finding. In fact, lower doses of 18 F-FDG, as used in the cohort of middle-aged overweight/obese adults, may increase noise in the image and, therefore, raise SUV peak levels 1, 8, 9 . We found that SUV max was located in BAT regions irrespective of the threshold used in young lean and young overweight/obese men. However, in middle-aged overweight/obese men, SUV max was found in an unexpected region when no threshold for HU was used. Therefore, omission of HU threshold may have resulted in an artificial SUV max and consequently SUV peak , especially in the middle-aged overweight-obese men who received a low dose of 18 F-FDG. Similar differences between thresholds and cohort studies were found with SUV max (data not shown). Therefore, in light of these findings, we support that SUV peak is the most consistent BAT-related outcome between criteria in the three independently cohorts of adults. Limitations. We quantified BAT in six different ROIs from cerebellum to thoracic vertebra 4 ( Figure S1 ).
Although most of the BAT detected in humans is localized in the areas covered by the selected ROIs 11 , we may have missed BAT depots in axillary, paraspinal or abdominal adipose tissue located in anatomical areas beneath the thoracic vertebra 4 11 . Our ROIs did not include mouth, nose, or thyroid to avoid false positive results, yet, results persisted when a single ROI from cerebellum to thoracic vertebrae 4 was drawn and when HU criteria were applied (data not shown). In addition, we do not know if these findings can be replicated when the SUV threshold of BARCIST criteria is used in combination with other ranges of HU. Besides the selection of HU and SUV thresholds, quantification of human BAT volume and activity also depends on other methodological issues such as the cooling protocol, 18 F-FDG-PET/CT methodology, segmentation software 17 , tracer used ( 18 F-FDG vs. 18 F-FTHA 24 ), intrinsic factors of the participants such as age, sex, or body composition, or extrinsic factors as outdoor temperature 25 or daily light 26 , which limit comparisons across studies. To improve the understanding of human BAT measured by 18 F-FDG-PET/CT, the reconstruction settings should be harmonized in a similar manner as proposed by the EANM guidelines for 18 F-FDG tumor PET imaging 27 . In the present study, the PET/ CT scans from young overweight/obese adults did not follow these guidelines, therefore we cannot guarantee that the recovery coefficients of the used reconstructions are the same. Moreover, methodological differences between cohorts did not allow us to check whether differences between HU and SUV thresholds are of different magnitude. Also the use of different cooling techniques (cooling vests vs. mattresses) and protocols might have introduced some bias. This study included only healthy male adults. The results should be applicable to other populations, such as women and men with different fat distributions, although this should be verified by replication in other cohorts with larger sample size. Moreover, biopsies of BAT-classical depots would be necessary to identify the density window (in terms of HU) of this tissue in different populations.
Conclusions
BAT volume and activity as determined by 18 F-FDG PET/CT highly depend on the quantification criteria used. Future human BAT studies should conduct sensitivity analysis with different thresholds in order to understand whether results are driven by the selected HU and SUV thresholds. According to our findings, when following an individualized cooling protocol, SUV peak is the most consistent marker of maximal BAT activity across study cohorts independent of the HU and SUV threshold used, which may therefore facilitate comparisons across studies. The design of the present study precludes providing any conclusive threshold, but before more definitive thresholds for HU and SUV are available, we support the use of BARCIST 1.0 criteria to facilitate interpretation of BAT characteristics between research groups.
